351
Participants
Start Date
November 30, 2003
Primary Completion Date
July 31, 2005
Study Completion Date
July 31, 2005
Civamide
Cream 0.075%, TID for 52 weeks
Seligman Center for Advanced Therapeutics, New York
Rheumatic Disease Associates, Ltd., Willow Grove
Radiant Research, Philadelphia
Clinical Research Center of Reading, LLP, West Reading
Chesapeake Medical Research, LLC, Baltimore
Arthritis and Rheumatic Diseases, Portsmouth
Piedmont Medical Group, Winston-Salem
NC Arthritis and Allergy Care Center, Raleigh
Raleigh Medical Group, PA, Raleigh
Radiant Research, Greer
Radiant Research, Atlanta
Radiant Research, Daytona Beach
University Clinical Research, DeLand
University Clinical Research Inc., Pembroke Pines
Robert W. Levin, MD, Dunedin
Innovative Clinical Trials, Birmingham
Summit Research Solutions, Memphis
University Hospitals of Cleveland, Beachwood
Hightop Medical Research Center, Cincinnati
Physicians Research Group, Indianapolis
Arthritis Clinic, Racine
Feinberg School of Medicine/Office of Clinical Rsrch and Trng, Chicago
Medex Healthcare Research Inc., St Louis
Center for Pharmaceutical Research, Kansas City
Heartland Research Associates, Wichita
Radiant Research, Austin
Radiant Research, Boise
University of Arizona, Tucson
New Mexico Research and Osteoporosis Center, Inc., Albuquerque
OMC Clinical Research Center, Beverly Hills
Boling Clinical Trials, Rancho Cucamonga
Med. Investigations, Fair Oaks
Physicians Pharmaceutical Study Services, Everett
Arthritis Regional Research Center, Mercerville
Winston Laboratories
INDUSTRY